Strategic Portfolio Adjustments
Flossbach Von Storch Discloses Major New Stakes in Fortive and Stryker Corp
Key Points
Flossbach Von Storch SE added 1,475,371 shares of Stryker, worth about $464.5 million, which represents roughly 2.1% of its portfolio and makes Stryker its 17th-largest holding.
Flossbach also purchased 12,107,839 shares of Fortive, valued at about $739.7 million, accounting for about 3.3% of its portfolio and ranking Fortive as the fund’s 11th-largest holding.
In MarketAxess, Flossbach acquired 75,000 shares (roughly $8.5 million). The period saw BlackRock add a new MarketAxess position in Q2 valued at about $454 million, underscoring substantial institutional activity around MKTX.
Coca-Cola Consolidated remained a focus for institutions, with Vanguard Group owning 5,686,058 shares valued at about $871.7 million after increasing its stake; Catalyst Investment Management also opened a new stake in Coca-Cola Consolidated in the second quarter.
Stryker's ownership landscape remains highly concentrated among institutions, with hedge funds and other institutional investors owning about 77.09% of the stock.
Flossbach Von Storch SE, a major investment firm, deployed roughly $2.2 billion in new stock positions during the second quarter, signaling aggressive portfolio expansion across industrial and medical sectors. The firm's largest new bet was a $739.7 million stake in Fortive Corporation—12.1 million shares that instantly became its 11th-biggest holding. Stryker and AMETEK also drew substantial capital, as Flossbach and peers like BlackRock repositioned holdings across healthcare and industrial equipment makers Ticker Report.
Fortive Becomes Flossbach's 11th Largest Position
Flossbach's boldest move targeted Fortive Corporation, acquiring 12.1 million shares for $739.7 million. The industrial software and manufacturing equipment company now accounts for 3.3% of Flossbach's $22 billion portfolio. This stake size places Fortive well above many of the firm's other recent purchases, reflecting confidence in the company's diversified business model across transportation and critical infrastructure Ticker Report.
Stryker and AMETEK Join Flossbach's Expanded Holdings
Flossbach simultaneously entered Stryker Corporation with 1.48 million shares worth $464.5 million, making it the firm's 17th-largest position. The medical device giant—which counts hedge funds and institutions as 77% shareholders—attracted Flossbach's capital at a time when institutional appetite for healthcare equipment remains strong. In a parallel move, Flossbach purchased 2.74 million AMETEK shares valued at $662 million, representing 3% of its portfolio Watchlist News, Ticker Report.
Coca-Cola Consolidated and MarketAxess Signal Broader Institutional Activity
Beyond industrial plays, Flossbach added 498,000 Coca-Cola Consolidated shares for $40.5 million, joining other major investors stepping into the beverage bottler. Vanguard Group holds over 5.6 million shares valued at $871.7 million, while Catalyst Investment Management opened a fresh position in Q2 Ticker Report. Flossbach also bought 75,000 MarketAxess shares for $8.5 million—a modest stake that follows BlackRock's $454 million entry into the financial software platform, underscoring competitive institutional interest in market infrastructure plays.
Portfolio Pruning: Flossbach Cuts MSCI Stake by Nearly One-Quarter
Not all Flossbach moves meant expansion. The firm reduced its MSCI Inc. position by 23.5%, trimming holdings to 169,324 shares worth $94.8 million. The reduction suggests shifting confidence in index provider valuations at current levels, even as the firm aggressively deploys capital elsewhere. The contrasting moves—buying $2.2 billion in new stakes while cutting MSCI—reveal a fund actively rotating toward industrial and healthcare sectors over pure-play financial infrastructure Ticker Report.
Sentiment
Mostly PositivePublishers
18
Articles
17
Reach
35
